Industry Focus

Two years ago we tossed out a terrible ballpark on the revenue Apple Music might be able to bring in for the tech giant. Today we talk about that mistake and how to set yourself up to make better projections.

Thanks to Harry’s for supporting Industry Focus. Get your free trial set – go to Harrys.com/fool

Direct download: 20170825_IF_Technology.mp3
Category:Podcast -- posted at: 3:30pm EST

Everyone makes mistakes, the important thing is to learn from them.

Direct download: 20170824_IF_Energy.mp3
Category:Podcast -- posted at: 3:30pm EST

We said what? Let’s face it, sometimes our predictions miss the mark, and with Rite Aid and Opko Health, they missed the mark by a lot. Here’s what we said, why we said it, and what we learned from our mistakes.

 

Direct download: 20170823_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

We said what?!? That is our theme for Industry Focus this week, and we continue the discussion with missed calls on Wal-Mart’s Jet.com acquisition and the 2,000 stores Amazon was supposed to open in the next several years.

Thanks to Harry’s for supporting the Motley Fool. Get your Free Trial Set -- go to Harrys.com/fool.

Direct download: 20170822_IF_ConsumerGoods.mp3
Category:Podcast -- posted at: 3:30pm EST

Everyone makes mistakes. But not many of us air them publicly. That's the theme of this week's Industry Focus, starting with our prediction in 2015 that concerns about Wells Fargo's cross-selling culture were much ado about nothing.

 

Direct download: 20170821_IF_Financials.mp3
Category:Podcast -- posted at: 3:30pm EST

We run through recent wearables market data from Strategy Analytics, check in on the major players, and talk about the long-term outlook for Fitbit.

Direct download: IF_Tech_08182017.mp3
Category:Podcast -- posted at: 3:09pm EST

A solar eclipse occurs Monday -- what that means for solar producers may surprise you.

Direct download: IF_08172017_AH.mp3
Category:Podcast -- posted at: 3:57pm EST

With a slate of promising drugs hitting the market and in its development pipeline, Regeneron Pharmaceuticals is becoming one of biotechs most important players.

Direct download: 20170816_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST

For several years, Procter & Gamble has been spinning off low-priority brands and cutting costs to streamline its business. But with little to show for those efforts, billionaire Nelson Peltz wants a seat at the table. Meanwhile, a slow summer blockbuster season is taking a major toll on theater operators.

Direct download: 20170815_IF_ConsumerGoods.mp3
Category:Podcast -- posted at: 3:35pm EST

Business development companies are undergoing a sea change as the asset class becomes more institutionalized.

Direct download: 20170814_IF_Financials.mp3
Category:Podcast -- posted at: 3:56pm EST